Latest filing published 12 Jun 2026 for Arcus Biosciences, Inc..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Yasunori Kaneko: trading record in brief
Yasunori Kaneko has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Arcus Biosciences, Inc. and Collegium Pharmaceutical, Inc. The record holds 15 filings, for trades running from 5 December 2017 to 11 June 2026.
On the market, this insider has only ever bought: 2 purchases, €300k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 7 share grants and 1 option exercise.
On 12 June 2026 came the latest disclosure, a share grant in Arcus Biosciences, Inc. The last insider purchase was made public on 27 February 2025, 620 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Yasunori Kaneko
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,700 sharesCommon StockSEC:0001277503-26-000003:0
- 13,300 shares0Common StockSEC:0001724521-25-000087:0
- 20,000 shares@ US$10.06100.0% of flowCommon StockSEC:0001724521-25-000046:0Canonical exit: 28 May 2025 (T+90)
- 8,400 shares0Common StockSEC:0001724521-24-000116:0
- 6,800 shares0Common StockSEC:0001209191-23-038141:0
- 4,100 shares0Common StockSEC:0001209191-22-037409:0
- 3,000 shares0Common StockSEC:0001209191-21-038619:0
7 of 7 declarations
